Fosamax is the brand name of a Merck & Co. drug product which
contains alendronic acid. Alendronic acid is prescribed to patients
with osteoporosis, a bone disease in which bone density declines,
leading to falls and fractures. Fosamax, as well as Fosamax +D which
contains additional Vitamin D, is used to treat osteoporosis by helping
patients grown new bone in place of that which has been lost. Merck's
patent for Fosamax expired in 2008, and the drug has since...
Read More